Tuberculosis is a significant global health threat, with onethird of the world's population infected with its causative agent Mycobacterium tuberculosis (Mtb). The emergence of multidrug-resistant (MDR)
Mtb that is resistant to the frontline anti-tubercular drugs rifampicin and isoniazid forces treatment with toxic second-line drugs. Currently, ~4% of new and ~21% of previously treated tuberculosis cases are either rifampicin-drug-resistant or MDR Mtb infections 1 . The specific molecular host-pathogen interactions mediating the rapid worldwide spread of MDR Mtb strains remain poorly understood. W-Beijing Mtb strains are highly prevalent throughout the world and associated with increased drug resistance 2 . In the early 1990s, closely related MDR W-Beijing Mtb strains (W strains) were identified in large institutional outbreaks in New York City and caused high mortality rates 3 . The production of interleukin-1β (IL-1β ) by macrophages coincides with the shift towards aerobic glycolysis, a metabolic process that mediates protection against drug-susceptible Mtb 4 . Here, using a collection of MDR W-Mtb strains, we demonstrate that the overexpression of Mtb cell wall lipids, phthiocerol dimycocerosates, bypasses the interleukin 1 receptor, type I (IL-1R1) signalling pathway, instead driving the induction of interferon-β (IFN-β ) to reprogram macrophage metabolism. Importantly, Mtb carrying a drug resistance-conferring single nucleotide polymorphism in rpoB (H445Y) 5 can modulate host macrophage metabolic reprogramming. These findings transform our mechanistic understanding of how emerging MDR Mtb strains may acquire drug resistance single nucleotide polymorphisms, thereby altering Mtb surface lipid expression and modulating host macrophage metabolic reprogramming.
The interferon gamma (IFN-γ ) 6 , tumour necrosis factor-α (TNF-α ) 7 , inducible nitric oxide synthase (iNOS) 8 , interleukin 1 receptor, type I (IL-1R1) 9 and myeloid differentiation primary response gene 88 (Myd88) 10 pathways are critical for host immunity to Mycobacterium tuberculosis (Mtb) infection. We determined whether these immune pathways are important for protection against both drug-susceptible and drug-resistant Mtb infection in vivo. As expected, Myd88 −/− , Ifnγr −/− , Tnfr1 −/− , Nos2 −/− and Il1r1 −/− mice show an increased lung burden following infection with a drug-susceptible W-Beijing Mtb strain (HN878; see Fig. 1a ,b) 11 . Mice deficient in IFN-α /β receptor (Ifnar −/− ) 12 and IL-10 (Il10 −/− ) 13 had similar lung burden compared to C57BL/6 J (B6) HN878infected mice (Fig. 1a ). Myd88 −/− , Ifnγr −/− , Tnfr1 −/− and Nos2 −/− mice also showed increased lung Mtb burden following infection with an MDR strain, W_7642 (Fig. 1a ). In contrast, Il1r1 −/− mice, similar to Ifnar −/− and Il10 −/− mice, controlled Mtb W_7642 infection ( Fig. 1a,b ). Increased susceptibility in HN878-infected Il1r1 −/− mice resulted in exacerbated pulmonary inflammation ( Fig. 1c , upper panel) and increased inflammatory myeloid cell accumulation ( Fig. 1d and Supplementary Fig. 1a ). Similar increased Mtb burden in Il1r1 −/− mice was observed following infection with a W-Beijing Mtb pyrazinamide-resistant strain HN563 ( Supplementary Fig. 2 ). HN878 and W_7642 infection in B6 mice resulted in comparable pulmonary inflammation ( Fig. 1c ), but differences in the recruitment of myeloid cell populations (Fig. 1d ). In contrast, W_7642-infected Il1r1 −/− mice did not exhibit exacerbated inflammation (Fig. 1c , lower panel), increased accumulation of inflammatory myeloid cells ( Fig. 1d and Supplementary Fig. 1a ) or altered accumulation of activated IFN-γ -producing CD4 + T cells ( Supplementary Fig. 1b ), when compared with the W_7642-infected B6 mice. Only a small increase in lung IL-6 protein levels in Il1r1 −/− W_7642-infected mice was observed compared with B6 W_7642-infected mice (Fig. 1e ). Thus, while several key protective immune pathways function in both drug-susceptible and MDR Mtb infection, IL-1R1 signalling is critical for protection against drug-susceptible Mtb infection but dispensable for immunity against an MDR Mtb strain.
Mtb infection of macrophages induces Toll-like receptor 2 (TLR2) stimulation, activation of protein kinase B (PKB/Akt) or 
Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes
is dispensable for protective immunity against W_7642. a, B6 (n = 10) and gene-deficient mice (Myd88 −/− HN878, n = 3; W_7642, n = 6; Ifngr −/− HN878, n = 5; W_7642, n = 6; Tnfr1 −/− , n = 4; Nos2 −/− , n = 5; Il1r1 −/− HN878, n = 9; W_7642, n = 5; Ifnar −/− , n = 5 and Il10 −/− , n = 5) were aerosol infected with 100 c.f.u. Mtb HN878 or W_7642. The lung bacterial burden was determined 30 days postinfection (d.p.i.) (a) or at defined time points (b; B6, n = 5; Il1r1 −/− , n = 9 except for W_7642-infected Il1r1 −/− mice 15 and 20 d.p.i. where n = 5). The red boxes highlight differences in Mtb control in HN878 and W_7642 infection. b, HN878-infected Il1r1 −/− mice were killed 30 d.p.i. due to severe tuberculosis disease. c, Formalin-fixed paraffin-embedded lung sections were stained with haematoxylin and eosin 30 d.p.i., and the inflammatory area was measured. Micrographs are representative images (× 5 magnification) from HN878-(top; B6, n = 9; Il1r1 −/− , n = 8) and W_7642-infected (bottom; n = 7) mice. Scale bars, 100 μ m. d, The total number of lung neutrophils, monocytes and recruited macrophages were determined 30 d.p.i. using flow cytometry (B6, n = 5; Il1r1 −/− , n = 4 and uninfected B6, n = 4). e, The cytokine and chemokine protein levels in lung homogenates were measured in B6 and Il1r1 −/− mice 30 d.p.i. (n = 5). UI, uninfected. Data points represent mean ± s.d. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ns, not significant (P > 0.05); one-way ANOVA with Tukey's post-test (a), two-way ANOVA with Bonferroni post-test (b,d,e) and two-tailed Student's t-test (c).
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NaTuRe MICRoBIoLogY mammalian target of rapamycin (mTOR) and a shift towards aerobic glycolysis to mediate Mtb control 4, 14 . Accordingly, macrophages infected with HN878 or W_7642 induced transcriptional pathways associated with a shift to aerobic glycolysis, including key enzymes such as lactate dehydrogenases (Ldha, Ldhb), 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (Pfkfb3) and aldolase A (Aldoa) ( Fig. 2a,c) . Interestingly, W_7642 infection resulted in a shut down of transcriptional networks associated with macrophage oxidative phosphorylation, including downregulation of NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (Ndufa1) and NADH:ubiquinone oxidoreductase subunit B5 (Ndufb5), key components of the macrophage oxidative phosphorylation complex (Fig. 2b,c) . Importantly, W_7642 infection induced a distinct type I IFN transcriptional signature, including Ifnb1-and IFN-induced genes such as MX dynamin-like GTPase 2 (Mx2), interferon induced protein with tetratricopeptide repeats (Ifit) 1, 2 and 3, as well as signal transducer and activator of transcription 1 (Stat1) (Fig. 2b,c) . Ifna transcripts were not detected by RNA sequencing. Increased lung IFN-β levels were found in W_7642-infected mice compared to HN878-infected mice ( Supplementary Fig. 3 ). Although induction of IL-1α mRNA and protein was similar, IL-1β mRNA and protein levels were significantly lower in W_7642 infection compared to HN878-infected macrophages ( Fig. 2c ,d) and coincided with increased IFN-β mRNA and protein levels in W_7642 infection compared to HN878-infected macrophages ( Fig. 2c,e ). These results were consistent at all time points measured and at varying multiplicity of infection (m.o.i.; Supplementary Fig. 4a -c). The IL-1R1 pathway negatively regulated IFN-β in HN878 infection, but it did not regulate IFN-β production following either in vitro or in vivo W_7642 infection ( Fig. 2e , Supplementary Fig. 3 ). Mtb-mediated induction of IL-1β occurred in a TLR2-, apoptosis-associated specklike protein containing a caspase recruitment domain (Asc)-and NLR family pyrin domain containing 3 (Nlrp3)-dependent manner following infection with either HN878 or W_7642 in myeloid cells ( Supplementary Fig. 5a ). W_7642-mediated induction of IFN-β was dependent on cyclic GMP/AMP synthase (cGAS) 15 and minimally on TLR2 ( Supplementary Fig. 5b ,c). In contrast, mRNA and protein levels of TNF-α were comparable in HN878-and W_7642-infected macrophages ( Fig. 2c,d ). When macrophages use aerobic glycolysis to generate energy, lactate is secreted as a by-product 4, 16 . W_7642 infection induced significantly lower accumulation of lactate than HN878 infection in macrophages ( Fig. 2d ). Nitrite levels, used as a measure of macrophage activation, did not differ significantly between HN878-and W_7642-infected macrophages (Fig. 2f ). In HN878 infection, lactate accumulation, macrophage activation and Mtb control were partly dependent on the IL-1R1-signalling pathway while IL-1R1 signalling was dispensable for the activation of macrophages and Mtb control in W_7642-infected macrophages ( Fig. 2d-g ). Blocking IFNAR did not impact IL-1β production in B6 HN878-infected macrophages, but it resulted in increased IL-1β and lactate production in B6 W_7642-infected macrophages ( Fig. 2h ). IFNAR blockade during W_7642 infection significantly reduced IL-1β and lactate production in Il1r1 −/− macrophages compared to B6 macrophages ( Fig. 2h ). Although IFNAR blockade in HN878infected Il1r1 −/− macrophages decreased Mtb colony-forming units (c.f.u.), IFNAR blockade in W_7642-infected Il1r1 −/− macrophages increased Mtb c.f.u. (Fig. 2i ). Co-infection with W_7642 and HN878 strains in macrophages (even at a 3:1 ratio of HN878/W_7642) decreased IL-1β and lactate production and increased IFN-β levels compared to HN878 infection alone ( Fig. 2j ). TNF-α levels remained unchanged in singly and co-infected macrophages ( Supplementary  Fig. 6 ). Thus, the presence of W_7642 can limit HN878-induced IL-1β and lactate accumulation in macrophages. Furthermore, macrophages treated with heat-killed (hk) W_7642 or with hkHN878 and hkW_7642 together, produced lower levels of IL-1β and lactate and higher IFN-β levels compared to macrophages treated with hkHN878 alone ( Supplementary Fig. 7a ). Thus, although Mtb replication is not required, an MDR Mtb cellular component limited IL-1β and aerobic glycolysis, while inducing IFN-β in macrophages. Using extracellular acidification rate (ECAR) as an indicator of glycolysis 17 , hkHN878 treatment induced significant ECAR in macrophages in which this response was partly IL-1R1 dependent ( Supplementary Fig. 7b ). However, hkW_7642 treatment, or co-treatment with hkHN878 and hkW_7642, induced significantly lower ECAR ( Supplementary Fig. 7b ). Additionally, HN878 infection induced lower IL-1β levels and negligible lactate levels in glucose-deprived galactose-containing medium in comparison to infection in glucose-containing medium (Fig. 2k ). In contrast, culturing W_7642-infected macrophages in galactose-containing medium minimally impacted IL-1β production or intracellular Mtb c.f.u. (Fig. 2k,l) . Low IFN-β levels were induced in HN878-infected macrophages cultured either in glucose-or galactose-containing media, when compared to the significantly higher IFN-β production in W_7642-infected macrophages cultured in glucose-containing media (Fig. 2k ). Thus, HN878 infection induced aerobic glycolysis to activate macrophages to mediate Mtb control, partly through the IL-1R1 pathway. In contrast, W_7642 is a poor inducer of IL-1β , instead inducing a potent IFN-β response and driving a less effective shift to aerobic glycolysis.
To delineate the specific molecular mechanism by which W_7642 activates macrophages, we used a collection of genetically conserved W-Mtb strains ( Fig. 3a ) that vary by a small number of single nucleotide polymorphisms (SNPs) by whole-genome sequencing (WGS) ( Fig. 3b , Supplementary Table 1 ). Interestingly, W_7642 has two non-synonymous SNPs (H445Y and G563A) within the Mtb rpoB, which encodes the β -subunit of Mtb RNA polymerase 5 . A closely related MDR Mtb strain (W12_1811) encodes a mutation within rpoB at a distinct site (S450L). Infection of Il1r1 −/− mice with W12_1811 resulted in increased lung Mtb c.f.u., pulmonary inflammation and myeloid cell accumulation compared to B6 mice infected with W12_1811 ( Fig. 3c and Supplementary Fig. 8a,b ). Additionally, W12_1811 infection in macrophages induced higher IL-1β and lactate production and lower IFN-β levels compared to W_7642-infected macrophages ( Fig. 3d,e ). Il1r1 −/− macrophages were also less effective at controlling W12_1811 infection in comparison to B6 macrophages ( Fig. 3f ). Thus, similar to HN878, W12_1811 uses the canonical IL-1R1 pathway to shift host metabolism towards aerobic glycolysis.
W12_1811 represents a divergent point in the New York City MDR W-Mtb family at which rifampicin resistance was gained 3 . We identified two other W12 strains (W12_15183 and W12_3474) where, similar to W_7642, W12_15183 contained both the rpoB-G563A and rpoB-H445Y SNPs, whereas W12_3474 only had the rpoB-H445Y SNP. In vivo infection with W12_15183 and W12_3474 resulted in comparable Mtb lung c.f.u. and pulmonary inflammation in both B6 and Il1r1 −/− infected mice ( Fig. 3c and Supplementary Fig. 8a ). Both strains also induced lower IL-1β and lactate levels and higher IFN-β production compared to W12_1811 (rpoB-S450L) infection ( Fig. 3d,e ). In addition, similar to W_7642 infection, in both W12_15183 and W12_3474 infections, Mtb control in macrophages was IL-1R1 independent ( Fig. 3f ). Furthermore, although hkW12_1811 treatment induced significant ECAR in macrophages, both hkW12_15183 and hkW12_3474 treatment induced lower ECAR and mirrored hkW_7642 ECAR induction ( Fig. 3g ). However, comparable Mtb growth kinetics in macrophages were observed ( Supplementary Fig. 8c ). From the 24 SNPs separating W12_1811 and W_7642, we eliminated SNPs for which W_7642 had the same sequence as lab-adapted Mtb H37Rv or HN878 ( Supplementary Table 1 ; 12 SNPs, highlighted in blue), as well as any SNPs that were unique to W_7642 ( Supplementary  Table 1 . h,i, Infected macrophages were treated with IFNAR-blocking antibody or isotype (25 μ g ml −1 ) at − 1 and 3 d.p.i. IL-1β (n = 5) and lactate levels (n = 4) were measured in the supernatants (h) and intracellular Mtb c.f.u. (i, n = 5) were determined 6 d.p.i. j, B6 macrophages (n = 5) were co-infected with HN878 and W_7642 (3:1 and 1:1 HN878/W_7642 ratios; total m.o.i. = 1) for 6 days IL-1β , lactate and IFN-β levels were measured in the supernatants. k,l, B6 macrophages in glucose or galactose (25 mM each)-containing media were infected with HN878 or W_7642. IL-1β (n = 6), lactate (n = 4) and IFN-β levels (n = 4) (k), and intracellular Mtb c.f.u. (l, n = 6) were determined 3 d.p.i. UN, untreated; UI, uninfected; nd; not detectable. Data points represent mean ± s.d. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001; ns, not significant (P > 0.05); gene set enrichment analysis using fgsea R package as in Methods (a,b); one-way ANOVA with Tukey's post-test (d-g,j,k); two-way ANOVA with Bonferroni post-test (h,i).
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highlighted in red). Thus we identified common SNPs in W_7642, W12_15183 and W12_3474 ( Supplementary Table 1 ; 2 SNPs, highlighted in yellow), narrowing down our WGS results to two SNPs that may be functional in mediating macrophage metabolism reprogramming: rpoB-H445Y and pykA-A369A, a pyruvate kinase A 18 .
However, the pykA SNP is synonymous, thus implicating the rpoB-H445Y SNP as potentially causal in macrophage reprogramming.
To validate a functional role for the rpoB-H445Y SNP in macrophage metabolic reprogramming, we therefore generated three HN878 clones independently under rifampicin selection carrying 
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NaTuRe MICRoBIoLogY either the rpoB-H445Y SNP or the rpoB-S450L SNP, but with no changes in the pykA gene. Importantly, infection of macrophages with independent clones of the HN878 rpoB-H445Y mutants (but not HN878 rpoB-S450L mutants), recapitulated the effects of W_7642 infection, with lower production of IL-1β and lactate, and increased induction of IFN-β compared to HN878 treatment and when infected at varying m.o.i. (Fig. 4a and Supplementary  Fig. 9a ). Furthermore, infection with HN878 rpoB-S450L resulted in increased Mtb c.f.u. in Il1r1 −/− macrophages compared with B6 macrophages at varying m.o.i. (Fig. 4b and Supplementary Fig. 9b ). In contrast, there was no difference in the intracellular c.f.u. of B6 and Il1r1 −/− macrophages infected with HN878 rpoB-H445Y at varying m.o.i. (Fig. 4b and Supplementary Fig. 9b ). Importantly, in vivo infection with HN878 rpoB-S450L resulted in increased pulmonary burden (Fig. 4c ), recruited macrophage accumulation and cytokine production in Il1r1 −/− mice, compared to infected B6 mice ( Supplementary Fig. 9c,e ). In contrast, infection with HN878 rpoB-H445Y resulted in comparable pulmonary bacterial burden ( Fig. 4c ) and no increase in myeloid cellular recruitment or cytokine levels ( Supplementary Fig. 9d,e ) between B6 and Il1r1 −/− mice. Additionally, infection of macrophages with HN878 rpoB-S450L (but not HN878 rpoB-H445Y) induced robust IL-1β and lactate accumulation in glucose-containing medium, but not very effectively in galactose-containing medium, suggesting that IL-1β induction is glucose dependent 4 ( Supplementary Fig. 9f ). Similarly, low IFN-β levels were induced in HN878 rpoB-S450L-infected macrophages cultured either in glucose-or galactose-containing media and IFN-β production was significantly enhanced in HN878 rpoB-H445Y-infected macrophages cultured in glucose-containing media ( Supplementary Fig. 9f ). These results demonstrate that the Mtb carrying the rpoB-H445Y SNP, but not rpoB-S450L, can modulate macrophage reprogramming to mediate Mtb control in the absence of IL-1R1 signalling. SNPs in Mtb rpoB give rise to rifampicin resistance 5 and are associated with broad transcriptomic changes, including the expression of secreted proteins and lipid biosynthetic intermediates [19] [20] [21] ; the nature of lipid changes may depend on the location of SNPs within the rpoB gene 21 . Furthermore, upregulation of the phthiocerol dimycocerosate (PDIM) biosynthetic operon 19 and increased PDIM expression is reported in rpoB-H445Y-resistant Mtb 21 . Thus, the rpoB-H445Y SNP in W_7642 may alter the composition of cell wall lipids and impact host sensing of Mtb for the reprogramming of macrophage metabolism. To address this, we identified PDIM changes in cell wall lipids between HN878 and W_7642. Cell wall lipids were purified from similar bacterial numbers and an internal triacylglycerol (TAG) standard was used to quantify the variation in lipids between the different strains. W_7642 showed increased relative abundance of long-chain multimethyl-branched fatty acid PDIMs in cell wall lipid preparations ( Fig. 4d,e ; see Supplementary  Fig. 10 for structural characterization of PDIM subclasses and Supplementary Fig. 11a,b for PDIM spectra) compared to the lower content of cell wall-associated PDIMs in HN878 (Fig. 4d,e and Supplementary Fig. 11a,b) . Notably, as found in a previous study 21 , when normalized to TAG, HN878 rpoB-H445Y Mtb recapitulated the presence of abundant long-chain multimethylbranched fatty acid PDIMs in cell wall lipid preparations (Fig. 4f,g and Supplementary Fig. 11c,d) , when compared to the PDIMs in HN878 rpoB-S450L (Fig. 4f,g and Supplementary Fig. 11c,d) . Importantly, the W12_1811 Mtb strain also expressed more shortchain fatty acid PDIMs ( Supplementary Fig. 12a,b ) in comparison to the long-chain fatty acid PDIMs present in cell wall lipid preparations from rpoB-H445Y-containing MDR Mtb strains W12-15183 ( Supplementary Fig. 12c ), W12-3474 ( Supplementary Fig. 12d ) and W_7642 ( Supplementary Fig. 12e ). This coincided with increased expression of enzymes involved in PDIM synthesis such as phenolpthiocerol synthesis type-I polyketide synthase (ppsA, ppsB and ppsC) in W_7642 ( Supplementary Fig. 11e ). Both HN878 rpoB-H445Y and rpoB-S450L had increased mRNA expression of these enzymes ( Supplementary Fig. 11f ). Thus, different rpoB SNPs may upregulate PDIM biosynthetic pathways. To test the physiological effects of the PDIMs on macrophage metabolic responses, Mtb-infected macrophages were exposed to HN878-derived PDIM-coated polystyrene beads, which resulted in reduced IL-1β and lactate, and increased IFN-β production (Fig. 4h ). Although Mtb-infected macrophages exposed to W_7642-derived PDIM-coated beads also suppressed IL-1β and lactate production and induced IFN-β , these changes were significant and occurred at lower PDIM-coated bead doses compared to the effects of HN878-derived PDIM-coated beads ( Fig. 4h and Supplementary Fig. 11g ). As for W_7642-derived PDIM-coated beads, PDIM-mediated metabolic rewiring occurred more robustly and at lower doses when Mtb-infected macrophages were treated with HN878 rpoB-H445Y-derived PDIM-coated beads, than with HN878 rpoB-S450L-derived PDIM-coated beads ( Fig. 4h and Supplementary Fig. 11g ). PDIM-coated beads alone did not impact cytokine or metabolic changes in uninfected macrophages (Fig. 4h) . Thus, while the abundance of PDIMs may directly induce IFN-β , limit IL-1β production and shift to aerobic glycolysis, the composition of PDIMs probably also contributes towards reprogramming macrophage metabolism during Mtb infection and needs to be investigated further.
Our limited knowledge of the immune parameters that mediate protection or drive disease progression during MDR Mtb infections is a significant hurdle to the current efforts to prevent worldwide emergence of MDR Mtb. We show here that Mtb carrying the widely prevalent rpoB-H445Y SNP 5 can alter macrophage metabolism through the induction of IFN-β and bypass the requirement for IL-1R1 pathway signalling for protective immunity. Although we did not carry out WGS on the independent rpoB-H445Y mutants, it is unlikely that the same type of secondary mutations would occur in each independent clone studied. Drug-resistant Mtb strains with the rpoB-H445Y and rpoB-S450L SNPs are both associated with overexpression of PDIMs 21 . However, treatment with long-chain fatty acid PDIMs from rpoB-H445Y more stringently inhibited glycolysis and induced IFN-β in macrophages compared to short-chain PDIMs from rpoB-S450L, suggesting that both the abundance and composition of PDIMs may impact macrophage metabolic rewiring. The S450L SNP did not exhibit major structural changes in the rifampicin binding site, whereas the H445Y SNP mediated structural changes in the binding site of Mtb RNA polymerase, thus preventing any binding of rifampicin 22 . It is possible that these differential structural changes in RNA polymerase may regulate the differential expression of Mtb cell wall lipids, including the composition of PDIMs and other lipids 21 , and needs to be fully explored in future studies. The presence of PDIM has been associated with decreased phagosomal acidification, phagosomal permeabilization 23 and increased Mtb escape from the intracellular vacuole into the cytosol 24 , where it may mediate increased sensing by the cytosolic DNA sensor cGAS and induction of IFN-β . A protective role for IL-1R1 signalling in Mtb infection is well known 9 , probably through the induction of the lipid mediator prostaglandin E2 25 and involvement in aerobic glycolysis within macrophages 4 . The type I IFN transcriptional signature is associated with pulmonary tuberculosis disease 26 and considered detrimental to immunity against drug-susceptible Mtb 25 . However, our results demonstrate that the IL-1R1 pathway is preferentially activated in drug-susceptible Mtb infection, whereas MDR Mtb strains preferentially induce IFN-β , which limits IL-1β induction, driving less effective aerobic glycolysis. Accordingly, in pulmonary infection in mice, although both MDR and drug-susceptible Mtb strains seemingly infect and induce tuberculosis disease, these infections recruit different inflammatory myeloid cells. Thus, the host immune metabolism induced in response to infection with drug-resistant Mtb may be substantially 31 . Pulmonary bacterial burden was determined at given time points through plating serial dilutions of lung homogenates on 7H11 agar plates.
Determination of rifampicin susceptibility. Independent rifampicin-resistant
Mtb HN878 clones (biological replicates) were selected from rifampicin (2 μ g ml −1 )containing 7H11 agar plates 32 . The sequences of rpoB and pykA in HN878 clones were confirmed by Sanger sequencing (Genewiz). Mtb stocks of three independent colonies for each SNP (rpoB-H445Y and-S450L) were cultured, stocked and the c.f.u. determined as described above for further experimentation.
To confirm drug resistance, HN878, HN878 rpoB-H445Y and rpoB-S450L were cultured on Middlebrook 7H10 agar plates at 35 °C in a 10% CO 2 atmosphere. Colonies no older than 2 weeks were transferred into a sterile tube containing 5.0 ml of water with 10-20 sterile glass beads. The suspension was vortexed for 1-2 min, allowed to stand for 15 min, then transferred to another tube and allowed to stand for 10 min. The supernatant was transferred into a sterile tube and the turbidity was adjusted to 0.5 McFarland standard with water. A 1:5 dilution of this suspension in water was used. A volume of 0.1 ml of each final drug solution and 0.8 ml oleic albumin dextrose catalase supplement were aseptically added into each Mycobacteria growth indicator tube containing 7.0 ml broth followed by 0.5 ml of the final inoculum suspension. Lyophilized drugs (BACTEC streptomycin, isoniazid, rifampicin, ethambutol and pyrazinamide drug kit; BD Biosciences) were dissolved according to the manufacturer's instructions. The final drug concentrations used were 0.1 μ g ml −1 for isoniazid, 1.0 μ g ml −1 for rifampin, 5 μ g ml −1 for ethambutol, 1.0 μ g ml −1 for streptomycin and 100 μ g ml −1 for pyrazinamide. Mtb ATCC 27294 was used as a control. Tubes were placed in the BACTEC MGIT 960 instrument that automatically interprets the results as susceptible or resistant. HN878 and Mtb 27294 were susceptible to all drugs tested, whereas HN878 rpoB-H445Y, rpoB-S450L was only resistant to rifampin.
In vitro cell culture of myeloid cells. Bone marrow cells from the femur and tibia of B6 and gene-deficient mice were extracted and 1 × 10 7 cells were cultured in 10 ml of complete Dulbecco's modified eagle's medium (cDMEM) supplemented with 20 ng ml −1 mouse recombinant (rm) granulocyte-macrophage colonystimulating factor (GM-CSF) (Peprotech) 31 . Relevant conditions were tested for mycoplasma contamination using PCR 33 . Cells were then cultured at 37 °C in 5% CO 2 . On day 3, 10 ml of cDMEM containing 20 ng ml −1 rmGM-CSF was added. On day 7, adherent cells were collected as macrophages and non-adherent cells were collected as dendritic cells.
Flow cytometry. Lung cell suspensions were prepared as described in a previous study 31 . Briefly, after perfusion with heparin in PBS, lungs were minced, digested with DNAse/collagenase, lysed for red blood cells and pressed through a 0.7 μ m filter to generate a single cell suspension. Cells were stained with appropriate fluorochrome-labelled specific antibodies or isotype control antibodies. Intracellular cytokine staining was performed using the BD Cytofix/Cytoperm kit (BD Biosciences). Mouse antibodies used included anti-CD11b (clone M1/70; Tonbo Biosciences), anti-CD11c (clone HL3; BD Biosciences), anti-Gr-1 (clone RB6-8C5; eBioscience), anti-CD3 (clone 500A2; BD Biosciences), anti-CD4 (clone RM4-5; BD Biosciences), anti-CD44 (clone IM7; eBioscience) and anti-IFN-γ (XMG1.2; BD Biosciences). Cells were processed with the Becton Dickinson (BD) Fortessa flow cytometer using FACS Diva software or the BD FACSJazz flow cytometer using FACS Sortware software (BD). Flow cytometry experiments were analysed using FlowJo (Tree Star Inc). As previously published 34 , neutrophils were defined as CD11b + CD11c -Gr-1 hi cells, monocytes were defined as CD11b + CD11c -Gr-1 med cells and recruited macrophages were defined as CD11b + CD11c -Gr-1 low cells. The total numbers of cells within each gate were back calculated on the basis of the cell counts per individual lung sample.
In vitro Mtb infection. Macrophages or dendritic cells were infected with Mtb (m.o.i. of 1 or 5) in antibiotic-free cDMEM. After varying d.p.i., supernatants were collected for the analysis of proteins or metabolites and RNA was extracted for downstream sequencing. Infected macrophages were washed rigorously with sterile PBS to remove non-phagocytosed Mtb, lysed with 0.05% sterile sodium dodecyl sulphate for 5 min, then plated in serial dilutions on 7H11 agar plates to estimate intracellular c.f.u. In some cases, macrophages were treated with IFNAR blocking antibody (clone MAR1-5A3; BioXcell) at 25 μ g ml −1 , on both − 1 and 3 d.p.i. In some experiments, macrophages were cultured in glucose-deprived cDMEM (Thermo Fisher) supplemented with D-glucose or D-galactose (25 mM; Sigma) for 24 h before infection with Mtb (m.o.i.= 1) as in earler work 4 . Cells were maintained in D-glucose-or D-galactose-supplemented media for the duration of infection (72 h).
Generation of hkMtb.
Heat-killed Mtb was generated by incubating Mtb cultures at 80 °C for 30 min. The protein content of each hkMtb stock was determined by bicinchoninic acid assay using the Pierce BCA Protein Assay Kit (Thermo Scientific), following the manufacturer's instructions. Macrophages were treated with hkMtb for 48 h (20 μ g ml −1 ) and culture supernatants were used for the analysis of proteins and metabolites.
Determination of proteins and metabolites. Cytokine and chemokine production in the lung homogenate of Mtb-infected B6 and Il1r1 −/− mice were analysed using Milliplex Multiplex Assays (Millipore). IL-1α and TNF-α were measured using Duoset kits (R&D Systems), IL-1β was measured using a BD OptEIA IL-1β ELISA Set (BD Biosciences), IFN-β was measured using a Legend Max Mouse IFN-β ELISA Kit (BioLegend), lactate accumulation was measured using a lactate assay kit (Sigma-Aldrich) and nitrite production was measured using the Griess Reagent System (Promega). Manufacturer's instructions were followed for all commercial kits.
Histology. Lung lobes were perfused with 10% neutral buffered formalin and embedded in paraffin (WUSM Elvie L. Taylor Histology Core Facility). Lung sections were stained with haematoxylin and eosin, and inflammatory features were evaluated by light microscopy. Inflammatory lesions were outlined with the automated tool of the Zeiss Axioplan 2 microscope (Carl Zeiss) and the percentage of inflammation was calculated by dividing the inflammatory area by the total area of individual lung lobes.
DNA isolation and sequencing. DNA was extracted from Mtb cultures for sequencing 35 . Mtb cultures were incubated for 30 min at 80 °C, then treated with 10% sodium dodecyl sulphate and proteinase K for 1 h at 60 °C. Proteins were precipitated with 5 M NaCl and 10% cetyl trimethylammonium bromide for 15 min at 60 °C. DNA was purified through the addition of chloroform:isoamyl alcohol (24:1) and precipitated with isopropanol at − 20 °C for 1 h. The DNA pellet was washed in 80% ethanol and dissolved in nuclease-free water. The Nextera DNA Library Preparation Kit was used for genome library preparation and WGS was performed using the Illumina NextSeq platform for Mtb strains. The resultant raw FASTQ data were trimmed using Sickle (https://github.com/ucdavisbioinformatics/sickle) and read alignment was performed by Burrows-Wheeler Aligner 36 using Mtb H37Rv (GenBank: AL123456) as the reference. Duplicate marking was done by Picard (http://broadinstitute.github.io/picard) and local realignment was performed using Genome Analysis Tool Kit 37 . SNPs and insertiondeletions were identified using Samtools 38 and VariScan 39 , followed by annotation using snpEff 40 . Potential variants were excluded if the mapping quality or the base quality score was below 20 or the minimum alternate fraction was below 0.75. SNPs located in the mobile genetic elements of the Pro-Glu (PE), Pro-Pro-Glu (PPE) and PE-Polymorphic GC-rich sequence (PGRS) gene regions that might cause incorrect read alignment were also excluded. A SNP maximum-likelihood phylogenetic tree was produced by RAxML 8.2.4. using the GTRGAMMA model 1 nature research | reporting summary
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection
All software used is reported in the methods under the "Flow cytometry," "DNA sequencing and isolation," or "RNA sequencing" sections.
Data analysis
All software used is reported in the methods under the "Flow cytometry," "DNA sequencing and isolation," "RNA sequencing, differential gene expression analysis and enrichment," or "Statistical analysis" sections.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability All relevant data are available from the authors. DNA sequencing data have been submitted under BioProject ID PRJNA353361. RNA sequencing data have been deposited in the Gene Expression Omnibus (GEO) database (accession number GSE115495).
